Can serum biomarkers predict the outcome of systemic immunosuppressive therapy in adult atopic dermatitis patients?
Abstract Background Atopic dermatitis (AD or eczema) is a most common chronic skin disease. Designing personalised treatment strategies for AD based on patient stratification is of high clinical relevance, given a considerable variation in the clinical phenotype and responses to treatments among pat...
Main Authors: | G. Hurault, E. Roekevisch, M. E. Schram, K. Szegedi, S. Kezic, M. A. Middelkamp‐Hup, P. I. Spuls, R. J. Tanaka |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-03-01
|
Series: | Skin Health and Disease |
Online Access: | https://doi.org/10.1002/ski2.77 |
Similar Items
-
Adipokines as Biomarkers of Atopic Dermatitis in Adults
by: Andrzej Kazimierz Jaworek, et al.
Published: (2020-09-01) -
Lymphopenia in atopic dermatitis patients treated with oral immunosuppressive drugs
by: Daphne S. Bakker, et al.
Published: (2018-10-01) -
Potential biomarkers of atopic dermatitis
by: Ling Yu, et al.
Published: (2022-11-01) -
A practical guide for transitioning from classical immunosuppressants to dupilumab in atopic dermatitis
by: Catherine M. Ludwig, et al.
Published: (2021-07-01) -
Atopic Dermatitis: Striving for Reliable Biomarkers
by: Styliani Mastraftsi, et al.
Published: (2022-08-01)